GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of ...

经过长达5年的法律斗争，GSK最终还是选择了和解。10月9日，GSK宣布就其胃灼热药物Zantac致癌问题诉讼案与10家原告公司达成和解，GSK需要为大约80000起诉讼支付22亿美元，为每位索赔人支付大约27500美元，避免其在美国面临的93%州诉讼案。同时，对首个发出Zantac致癌风险警告的美国独立实验室Valisure，GSK也同意了以7000万 ...

GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its ...

GSK Plc said it will pay as much as $2.2 billion to resolve about 80,000 US court cases related to allegations that its old ...

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...

智通财经获悉，葛兰素史克(GSK.US)周三宣布，该公司已同意支付高达22亿美元，以解决美国州法院提起的大多数诉讼，这些诉讼指控一种已停产的胃灼热药物Zantac会导致癌症。该公司说，与10家原告律师事务所达成的协议解决了约8万起案件，占美国全国州法 ...

领先的制药公司GSK plc (NYSE:GSK)今天宣布达成和解,以解决美国州法院大多数未决的Zantac(雷尼替丁)产品责任案件。该公司将支付高达22亿美元来解决约8万起案件,占针对该公司索赔的93%。此外,GSK原则上同意以7000万美元和解Valisure提起的qui tam诉讼。 这些和解并不意味着GSK承认任何责任,预计将在2025年上半年末前全面实施。GSK坚持认为,没有确凿的科学证 ...

葛兰素史克公司周三表示，已与10家原告公司达成协议，这些公司占美国州法院针对该制药商的Zantac产品责任案件的93%，和解金额高达22亿美元。

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits ...

The British drugmaker reached a $2.2 billion settlement to resolve around 80,000 lawsuits over claims its Zantac heartburn ...

GSK settles 93% of Zantac lawsuits with a $2.2 billion payout, easing investor concerns. However, doubts over its future ...